Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$415.54 USD

415.54
1,080,848

+9.06 (2.23%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $415.66 +0.12 (0.03%) 7:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 5% (13 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HCA Holdings (HCA) Q3 Earnings Lag Estimates

by Zacks Equity Research

HCA (HCA) delivered earnings and revenue surprises of -28.62% and 0.04%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

HCA Healthcare (HCA) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

HCA Healthcare's (HCA) third-quarter 2020 results are likely to reflect higher revenues owing to the gradual rise in patient volumes following the easing of government restrictions.

Here's Why You Should Retain Universal Health (UHS) for Now

by Zacks Equity Research

Riding high on its solvency position, strong segments and strategic initiatives, Universal Health (UHS) holds potential to reap benefits.

Here's Why You Should Retain Tenet Healthcare (THC) Stock

by Zacks Equity Research

Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

David Borun headshot

A Volatile Week Ends with Stocks Broadly Higher

by David Borun

Stimulus talks grind on, but equity investors seem to be pricing in a big package.

HCA Healthcare (HCA) Announces Preliminary Results for Q3

by Zacks Equity Research

HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.

Here's Why You Should Stay Away From HCA Healthcare Now

by Zacks Equity Research

HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.

HCA Healthcare, EVERFI's Course to Enhance Behavioral Health

by Zacks Equity Research

HCA Healthcare (HCA) forms alliance with EVERFI, which provides middle and high school students with a digital course to address mental health disorders.

Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC

by Zacks Equity Research

Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC

Sapna Bagaria headshot

4 Hospital Stocks to Gain from Improving Admissions, Federal Aid

by Sapna Bagaria

Federal relief, higher admissions and cost containment are likely to aid the Zacks Medical-Hospital industry. HCA, UHS, CYH and THC are well-positioned to gain from a revival in admissions.

Here's Why Investors Should Bet on Ensign Group Stock Now

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth on the back of improving revenues, strategic buyouts and sound capital position.

Debanjana Dey headshot

3 Stocks to Buy From Strong MedTech Spaces Amid the Pandemic

by Debanjana Dey

Here are three stocks from three sub-sectors from MedTech that have held their ground despite the pandemic-led market mayhem.

David Borun headshot

Stocks Mixed as Tech Rises but Banks Stumble

by David Borun

The SCOTUS vacancy, the upcoming election and continued efforts at new fiscal stimulus make things interesting in the equity markets.

The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA

by Zacks Equity Research

The Zacks Analyst Blog Highlights: UNH, CNC, HUM, ANTM and HCA

Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

by Zacks Equity Research

Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

Zacks.com featured highlights include: SFM, ORLY, RUSHA, DPZ and HCA

by Zacks Equity Research

Zacks.com featured highlights include: SFM, ORLY, RUSHA, DPZ and HCA

UHS or THC: Which is a Better-Positioned Stock Right Now?

by Zacks Equity Research

Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.

Uncertainty Over Supreme Court Ruling Weighs on Healthcare

by Zacks Equity Research

Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.

Sumit Singh headshot

Tap These 5 Stocks With Amazing Interest Coverage Ratio

by Sumit Singh

The company's creditworthiness depends on how effectively it meets its interest obligations.

Are Investors Undervaluing HCA Holdings (HCA) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why Should You Retain MEDNAX (MD) in Your Portfolio Now?

by Zacks Equity Research

Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.

Why Should You Add Universal Health (UHS) to Your Portfolio?

by Zacks Equity Research

Riding high on segmental contributions and a solid balance sheet, Universal Health (UHS) has potential to reap benefits for investors.

What Makes Select Medical (SEM) an Attractive Investment Pick

by Zacks Equity Research

Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.

MEDNAX Divests Radiology Business to Focus on Core Operations

by Zacks Equity Research

MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.

Why Should You Hold on to Tenet Healthcare (THC) Stock?

by Zacks Equity Research

Riding high on divestitures and cost-reduction, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.